Swiss National Bank »

Aeglea Biotherapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.6M 69k 23.28
2024-09-30 $1.5M 50k 29.41
2024-06-30 $849k 36k 23.51
2024-03-31 $1.5M 39k 37.93